PTGS2 and posterior cortical atrophy: However, reduced expression of PTGS2 mRNA by promoter hypermethylation has been reported to be an indicator of poor prognosis in PCa [57] and the COX-2 inhibitor celecoxib does not improve PCa patient survival [58].